Skip to main content
. 2016 Nov 21;31(5):e22099. doi: 10.1002/jcla.22099

Table 1.

Mass fraction and current CVs of control materials and percentages of laboratories meeting different quality requirements for HbA1c (%)

Year Number of labsa Mass fraction Current CVs Allowable imprecision specifications based on NACB and biological variation
Median IQRb Median IQRb P d NACBc Minimum Desirable Optimal
Level 1
2012 306 5.68 0.57 2.60 2.88 <.001 39.9 24.5 10.1 4.9
2013 306 5.67 0.49 2.09 1.77 47.0 23.1 8.0 3.6
2014 306 5.35 0.64 1.90 1.58 53.5 26.2 8.5 3.2
2015 306 5.34 0.58 1.90 1.56 54.3 33.2 12.5 4.3
2016 306 5.45 0.63 1.61 1.52 63.4 40.7 18.1 4.9
Level 2
2012 147 9.46 0.68 2.39 2.35 <.001 44.2 32.0 12.2 4.1
2013 158 9.60 0.97 1.83 1.49 56.3 28.1 13.3 3.1
2014 173 9.58 0.78 1.78 1.46 63.7 38.9 8.3 0.6
2015 171 9.69 0.73 1.53 1.13 69.9 46.8 20.5 3.2
2016 177 9.83 0.67 1.49 0.94 72.3 52.5 19.1 3.5
a

The data in this row reflect the number of laboratories which have submitted the information of current CVs for level 1 and level 2.

b

Interquartile range (IQR) is equal to the difference between the upper and lower quartiles, IQR=Q3‐Q1.

c

Analytical imprecision criteria based on National Academy of Clinical Biochemistry (NACB) was set as <2% within laboratory.

d

Differences in current CVs in different years were tested by Friedman M test.